Concepedia

Devin T. Wiley

DT

4

Publications

829

Citations

4

H-Index

2013

Active since

Affiliations

California Institute of Technology(Current)

City of Hope

Taipei Medical University

Cerulean Pharma (United States)

Devin T. Wiley is an author at California Institute of Technology specializing in nanomedicine, medicine, and engineering.

Top concepts

Publications per year

2013–2017

4

Publications

4

Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor

Devin T. Wiley, Paul Webster, Aaron Gale et al. · Proceedings of the National Academy of Sciences · 2013 · 489 citations · Full text

, , +20

CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing

Andrew J. Clark, Devin T. Wiley, Jonathan E. Zuckerman et al. · Proceedings of the National Academy of Sciences · 2016 · 166 citations · Full text

, , +21

Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle

Scott Eliasof, Douglas Lazarus, Christian Peters et al. · Proceedings of the National Academy of Sciences · 2013 · 141 citations · Full text

, , +15

Pilot trial of CRLX101 in patients with advanced, chemotherapy-refractory gastroesophageal cancer

Joseph Chao, James Lin, Paul Frankel et al. · Journal of Gastrointestinal Oncology · 2017 · 33 citations · Full text

Rows per page

1–4 of 4